Effect of a novel agent, SL-401, targeting interleukin-3 (IL-3)-receptor on plasmacytoid dendritic cell (pDC)-induced myeloma cell growth and drug resistance.

Authors

null

Dharminder Chauhan

Dana-Farber Cancer Institute, Boston, MA

Dharminder Chauhan , Arghya Ray , Christopher Brooks , Eric K. Rowinsky , Kenneth Carl Anderson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Multiple Myeloma

Citation

J Clin Oncol 31, 2013 (suppl; abstr 8582)

DOI

10.1200/jco.2013.31.15_suppl.8582

Abstract #

8582

Poster Bd #

53C

Abstract Disclosures